Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
InMode ( (INMD) ) has issued an announcement.
On February 23, 2026, InMode Ltd. announced that an independent transaction committee of its board has completed a comprehensive review of proposals related to a potential transaction. After working with external financial and legal advisers, the committee determined that none of the final offers was adequate or in the best interests of the company and its shareholders, and decided to discontinue the process for now.
InMode said it will continue to evaluate its business, growth and cash allocation strategies with an emphasis on enhancing long-term shareholder value. The company also indicated it does not plan to provide further updates on the terminated review process unless it deems additional disclosure necessary, signaling a return of strategic focus to internal execution rather than transformational deals.
The most recent analyst rating on (INMD) stock is a Hold with a $16.50 price target. To see the full list of analyst forecasts on InMode stock, see the INMD Stock Forecast page.
Spark’s Take on INMD Stock
According to Spark, TipRanks’ AI Analyst, INMD is a Outperform.
The score is driven primarily by strong underlying financial quality (high margins, strong cash conversion, and a very conservative balance sheet). Offsetting that strength are weakened growth and profitability trends and a conservative 2026 outlook that implies flat revenue and lower margins/EPS. Technicals are mildly constructive and valuation is relatively low, but both are secondary to the near-term fundamental trajectory.
To see Spark’s full report on INMD stock, click here.
More about InMode
InMode Ltd. is a global provider of innovative medical technologies that develops, manufactures and markets devices based on novel radio frequency technology. The company focuses on minimally invasive and emerging surgical procedures, offering a broad portfolio for plastic surgery, gynecology, dermatology, otolaryngology and ophthalmology across international markets.
Average Trading Volume: 903,567
Technical Sentiment Signal: Sell
Current Market Cap: $916.2M
See more insights into INMD stock on TipRanks’ Stock Analysis page.